HF
IRLA

HRT Financial’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

HRT Financial’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73
Closed -$19K – 3375
2025
Q1 		$19K Sell
73
-28
-28% -$8.55K ﹤0.01% 2308
2024
Q4 		$37K Buy
+101
New +$30.3K ﹤0.01% 2138
2021
Q4 		– Sell
-72
Closed -$1.31M – 3903
2021
Q3 		$1.31M Buy
+72
New +$1.15M 0.01% 1044

Other funds holding IRLA

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

HRT Financial's IRLA Position: Q2 2025 in Review

HRT Financial sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2025, closing a stake of 73 shares — an estimated $19K sold.

HRT Financial first reported a position in IRLA in Q3 2021 and held it in 3 quarters. The position peaked at $1.31M in Q3 2021. 37 funds tracked by Wall St. Rank hold IRLA as of Q2 2025.

  • HRT Financial reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 73 IRulya Therapeutics Inc. Common Stock shares in Q2 2025, an estimated $19K.
  • HRT Financial first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • HRT Financial's IRulya Therapeutics Inc. Common Stock position peaked at $1.31M in Q3 2021.
  • 37 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.